Overview
Buse Cevatemre practices practicing medicine in Istanbul, Turkey.
Her clinical expertise encompasses Prostate Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Necrosis.
She is actively involved in clinical research, co-authoring 35 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Buse Cevatemre
Is Buse Cevatemre a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Buse Cevatemre is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Buse Cevatemre participate in research or clinical trials?
Yes. Buse Cevatemre has published 35 articles and abstracts on conditions like Prostate Cancer. You can view a list of Buse Cevatemre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Cevatemre isExperienced. Learn about Breast Cancer.
- NecrosisMs. Cevatemre isExperienced. Learn about Necrosis.
- Prostate CancerMs. Cevatemre isExperienced. Learn about Prostate Cancer.
- Triple-Negative Breast CancerMs. Cevatemre isExperienced. Learn about Triple-Negative Breast Cancer.